Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 深圳迈瑞生物医疗电子股份有限公司主要从事医疗器械的研发、制造、营销及服务,主要产品涵盖三大领域:生命信息与支持、体外诊断以及医学影像。公司总部设在中国深圳,在北美、欧洲、亚洲、非洲、拉美等地区的超过30个国家设有40家境外子公司;在国内设有17家子公司,超过40家分支机构,形成了庞大的全球化研发、营销及服务网络。公司荣获“2022年度中国医疗设备优秀民族品牌金奖”、“2022峰值TOP2022年度南山区经济突出贡献企业--工业增加值十强”、“2022年度南山区纳税百强企业(十强)”、“2022年度广东省质量信用A类医疗器械生产企业”、2022年度WindESG最佳实践上市公司-A股最佳实践奖、2022年度WindESG最佳实践上市公司-A股医疗保健行业最佳实践奖、2022中国医药上市公司ESG竞争力TOP20、第十六届中国上市公司ESG百强、2022年度中经大健康高质量发展企业、第五届中国卓越IR·2021-2022最佳ESG奖、第五届中国卓越IR·2021-2022最佳ESG奖、2022卓越社会责任企业、2023中国宠物医疗行业年度品牌盛典年度科技创新品牌奖和年度筑梦人才品牌奖、瑞派宠物医院突出贡献奖。 | ||||||||||||||||||||||||
Main Business | 从事医疗器械的研发、制造、营销及服务,始终以客户需求为导向,致力于为全球医疗机构提供优质产品和服务。 | ||||||||||||||||||||||||
Legal Representative | 李西廷 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 李文楣 | ||||||||||||||||||||||||
Solicitors | 上海市方达律师事务所 | ||||||||||||||||||||||||
Auditors | 普华永道中天会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0755-81888398 | ||||||||||||||||||||||||
Fax No | 0755-26582680-88398 | ||||||||||||||||||||||||
Website | www.mindray.com | ||||||||||||||||||||||||
ir@mindray. com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 16/10/2018 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 9.636 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 6.270 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 29.574 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 271.582B |
![]() |
Only Chinese content is avaliable |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |